ACTA1 and Hepatic fibrosis: Our data demonstrated that EPZ‐6438 administration mitigated the severity of TAA‐induced hepatic fibrosis, as represented by H&E, Masson's trichrome, Sirius red staining, as well as α‐SMA immunostaining (Figure 8B).